A Randomized Double-Blind, Placebo-Controlled Study on Anti-Stress Effects of Nelumbinis Semen

Int J Environ Res Public Health. 2022 Jun 29;19(13):7963. doi: 10.3390/ijerph19137963.

Abstract

Introduction: Depression is a serious and common mental disease that causes low mood and loss of interest in activities. Nelumbinis semen (NS) has been widely used as a treatment for depression for hundreds of years in many Asian countries. Water extract of nelumbinis semen (WNS) is a standardized herbal medicine made from NS. Methods: The objective of the present research was to perform a randomized, double-blind, placebo-controlled trial to estimate the efficacy of WNS for improving depressive and stress symptoms using Beck depression inventory (BDI) and the stress response inventory (SRI) in 45 adults diagnosed with major depression or other forms of depressive disorders. They were randomized to either a placebo-treated group, a 2.4 g per day WNS-treated group, or a 4.8 g per day WNS-treated group. BDI and SRI were determined in order to evaluate changes in depression before and after two weeks of WNS treatment. Results: The average BDI and SRI of the 2.4 g WNS-treated group were significantly (p < 0.05) improved compared to those of the placebo-treated group. Their BDI subscale A (negative attitudes towards self) and subscale C (somatic disturbances), SRI E, and depression subscale of SRI were substantially shorter (p < 0.05). In addition, an analysis of collected EEG data of participants showed a significant increase in alpha/beta activity in the 4.8 g WNS-treated group, which might be explained as an advancement of their depression symptoms (p < 0.05). Conclusions: These results suggest that WNS treatment can decrease depression. Our study provides preliminary evidence for the safety of WNS and its potential to decrease depression.

Keywords: Beck depression inventory (BDI); depressive disorder; electroencephalography (EEG); nelumbinis semen (NS); stress response inventory (SRI).

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Depression / drug therapy
  • Depressive Disorder, Major* / diagnosis
  • Double-Blind Method
  • Drugs, Chinese Herbal* / therapeutic use
  • Humans
  • Psychiatric Status Rating Scales
  • Treatment Outcome

Substances

  • Drugs, Chinese Herbal
  • Nelumbinis Semen

Grants and funding

This research was supported by a grant from Kyung Hee University in 2021 (KHU-20210141), the National Research Foundation of Korea (NRF-2021R1A2C1093825) and VTBIO Co., LTD.